DHINGRA, S.; SACHDEVA, M. Expanding horizons in the treatment of mantle cell lymphoma: Ibrutinib a novel BTK-targeting inhibitor. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 3, n. 1, p. 249–254, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/991. Acesso em: 24 nov. 2025.